Nuvectis Pharma, Inc.
NVCT
Revenue
0.00
0.000.00%
-Assets
18.30M
▼-1.42M▼-7.18%
3 Months ChangeLiabilities
5.77M
▲78.00k▲1.37%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-29
Form 8-K
ID: 0001104659-24-094609
2024-08-06
Form 10-Q
ID: 0001558370-24-010971
2024-08-06
Form 8-K
ID: 0001104659-24-086127
2024-06-13
Form 8-K
ID: 0001104659-24-071261
2024-05-07
Form 10-Q
ID: 0001558370-24-007072
2024-05-07
Form 8-K
ID: 0001104659-24-057782
2024-03-05
Form 8-K
ID: 0001104659-24-030773
2023-11-08
Form 8-K
ID: 0001104659-23-115538
2023-11-08
Form 10-Q
ID: 0001558370-23-018124
2023-09-12
Form 8-K
ID: 0001104659-23-099872